These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35988111)

  • 1. The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials.
    Arabi SM; Chambari M; Malek-Ahmadi M; Bahrami LS; Hadi V; Rizzo M; Sahebkar A
    Inflammopharmacology; 2022 Oct; 30(5):1597-1615. PubMed ID: 35988111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Statin/Ezetimibe for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Asian Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Bhagavathula AS; Aldhaleei WA; Al Matrooshi NO; Rahmani J
    Clin Drug Investig; 2020 Sep; 40(9):809-826. PubMed ID: 32671595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Jamialahmadi T; Baratzadeh F; Reiner Ž; Simental-Mendía LE; Xu S; Susekov AV; Santos RD; Sahebkar A
    Mediators Inflamm; 2021; 2021():9661752. PubMed ID: 34526854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis.
    Hameed I; Shah SA; Aijaz A; Mushahid H; Farhan SH; Dada M; Khan AB; Amjad R; Alvi F; Murtaza M; Zuberi Z; Hamza M
    Am J Cardiovasc Drugs; 2024 May; 24(3):419-431. PubMed ID: 38578578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of C-reactive protein, low-density lipoprotein cholesterol, and its relationship with cardiovascular events of different lipid-lowering therapies: A systematic review and meta-analysis of randomized controlled trials.
    Yang W; Cai X; Lin C; Lv F; Zhu X; Han X; Ji L
    Medicine (Baltimore); 2022 Sep; 101(37):e30563. PubMed ID: 36123891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis.
    Dolezelova E; Stein E; Derosa G; Maffioli P; Nachtigal P; Sahebkar A
    Br J Clin Pharmacol; 2017 Jul; 83(7):1380-1396. PubMed ID: 28166606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Different Statin-Based Lipid-Lowering Strategies on C-Reactive Protein Levels in Patients With Stable Coronary Artery Disease.
    Xue Z; Ye M; Jiang H; Li D; Hong X; Chen Z; Li Y; Zhou B; Zhang W; Wang M
    Clin Cardiol; 2024 Jun; 47(6):e24301. PubMed ID: 38895772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
    Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Combination Therapy with Ezetimibe and Statins versus Statin Monotherapy on Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Kwon RJ; Cho YH; Park EJ; Lee Y; Lee SR; Choi JI; Lee SY; Son SM
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004029
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of combination therapy with statins and ezetimibe on proinflammatory cytokines: A systematic review and meta-analysis of randomized controlled trials.
    Mostafa Arabi S; Sadat Bahrami L; MalekAhmadi M; Chambari M; Milkarizi N; Orekhov AN; Sahebkar A
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109477. PubMed ID: 36417822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.
    Mikhailidis DP; Sibbring GC; Ballantyne CM; Davies GM; Catapano AL
    Curr Med Res Opin; 2007 Aug; 23(8):2009-26. PubMed ID: 17659159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature.
    Yu M; Liang C; Kong Q; Wang Y; Li M
    Lipids Health Dis; 2020 Jan; 19(1):1. PubMed ID: 31900179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.
    Ara R; Tumur I; Pandor A; Duenas A; Williams R; Wilkinson A; Paisley S; Chilcott J
    Health Technol Assess; 2008 May; 12(21):iii, xi-xiii, 1-212. PubMed ID: 18485273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.
    Abramson BL; Benlian P; Hanson ME; Lin J; Shah A; Tershakovec AM
    Lipids Health Dis; 2011 Aug; 10():146. PubMed ID: 21859459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high-dose statin versus low-dose statin plus ezetimibe on endothelial function: a meta-analysis of randomized trials.
    Ye Y; Zhao X; Zhai G; Guo L; Tian Z; Zhang S
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):357-65. PubMed ID: 22710021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy.
    Lorenzi M; Ambegaonkar B; Baxter CA; Jansen J; Zoratti MJ; Davies G
    Clin Res Cardiol; 2019 May; 108(5):487-509. PubMed ID: 30302558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ezetimibe on markers of inflammation in patients treated with statins: a systematic review.
    Klement M; Drexel H; Saely CH
    Inflammopharmacology; 2023 Aug; 31(4):1647-1656. PubMed ID: 37261626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Kandelouei T; Abbasifard M; Imani D; Aslani S; Razi B; Fasihi M; Shafiekhani S; Mohammadi K; Jamialahmadi T; Reiner Ž; Sahebkar A
    Mediators Inflamm; 2022; 2022():8732360. PubMed ID: 35125965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis.
    Mikhailidis DP; Lawson RW; McCormick AL; Sibbring GC; Tershakovec AM; Davies GM; Tunceli K
    Curr Med Res Opin; 2011 Jun; 27(6):1191-210. PubMed ID: 21473671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.